Yuhong Du

5.3k citations

96 papers · 3.0k indexed · h-index 34

Impact in

Molecular Medicine top 2%
- Curcumin's Biomedical Applications
Molecular Biology top 5%
- 14-3-3 protein interactions
- Ubiquitin and proteasome pathways
- Natural product bioactivities and synthesis

Papers in

Molecular Biology 79
- Ubiquitin and proteasome pathways 20
- 14-3-3 protein interactions 19
- Protein Degradation and Inhibitors 7
- ATP Synthase and ATPases Research 6
- Heat shock proteins research 6
Virology 4

Co-authors: Haian Fu Fadlo R. KhuriJing ZhaoMin Qui Raymond Dingledine Aiming Sun James P. Snyder Xiulei Mo
Journals: Journal of Molecular Cell Biology (6 papers)Proceedings of the National Academy of Sciences (6 papers)Assay and Drug Development Technologies (5 papers)SLAS DISCOVERY (5 papers)Journal of Medicinal Chemistry (5 papers)
Partner nations: United States China Canada

In The Last Decade

Yuhong Du

91 papers receiving 3.0k citations

Peers

Countries citing papers authored by Yuhong Du

Since Specialization

Citations

This map shows the geographic impact of Yuhong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuhong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuhong Du more than expected).

Fields of papers citing papers by Yuhong Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuhong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuhong Du. The network helps show where Yuhong Du may publish in the future.

Co-authors

The 25 scholars most cited alongside Yuhong Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuhong Du Line = papers co-authored together Yuhong Du links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Non-Catalytic Inhibitors of the p38/MK2 Interface: Repurposing Approved Drugs to Target Neuroinflammation in Alzheimer’s Disease Journal of Medicinal Chemistry ·Ming Hu, Andrew Li, P.R. Fleming, Jan Gralla, Kristos Negrón Terón, Ying Zhou, Eric J Miller, Tyler S. Beyett, Zhexing Wen, Yuhong Du, Haian Fu, Andrei A. Ivanov	2025	0
2	Identification and characterization of a TGF- β -independent SMAD4–NFATc1–STAT3 regulatory axis Journal of Molecular Cell Biology ·Wukun Ouyang, Jiaying Hao, Qiankun Niu, Eugene F. Douglass, Christian M. Beusch, David E. Gordon, Michael N. Hall, Richard Moffit, Yuhong Du, Xiulei Mo	2025	0
3	Discovery of FERM domain protein–protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer’s disease Journal of Biological Chemistry ·Yuhong Du, W.J. Bradshaw, Tina M. Leisner, Joel K. Annor‐Gyamfi, Kun Qian, Frances M. Bashore, Arunima Sikdar, Felix O. Nwogbo, Andrei A. Ivanov, Stephen V. Frye, O. Gileadi, Paul E. Brennan, Allan I. Levey, Alison D. Axtman, Kenneth H. Pearce, Haian Fu, V.L. Katis	2023	8
4	Human beige adipocytes for drug discovery and cell therapy in metabolic diseases Nature Communications ·Amar M. Singh, Liang Zhang, John Avery, Amelia Yin, Yuhong Du, Hui Wang, Zibo Li, Haian Fu, Hang Yin, Stephen Dalton	2020	48
5	Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer Molecular Cancer Therapeutics ·Yang Yang, Kenza Mamouni, Xin Li, Yanhua Chen, Sravan Kavuri, Yuhong Du, Haian Fu, Ömer Küçük, Daqing Wu	2018	20
6	Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction Assay and Drug Development Technologies ·Jinglin Xiong, Valentina González-Pecchi, Min Qui, Andrei A. Ivanov, Xiulei Mo, Qiankun Niu, Xiang Chen, Haian Fu, Yuhong Du	2018	15
7	Screening and Functional Profiling of Small-Molecule HIV-1 Entry and Fusion Inhibitors Assay and Drug Development Technologies ·Charline Giroud, Yuhong Du, Mariana Marin, Qui Min, Nathan T. Jui, Haian Fu, Gregory B. Melikyan	2017	5
8	Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer’s disease Nature Communications ·Zhentao Zhang, Obiamaka Obianyo, Elfriede Dall, Yuhong Du, Haian Fu, Xia Liu, Seong Su Kang, Mingke Song, Shan Ping Yu, Chiara Cabrele, Mario Schubert, Xiaoguang Li, Jian–Zhi Wang, Hans Brandstetter, Keqiang Ye	2017	115
9	High-Throughput HIV–Cell Fusion Assay for Discovery of Virus Entry Inhibitors Assay and Drug Development Technologies ·Mariana Marin, Yuhong Du, Charline Giroud, Jeong Hwa Kim, Min Qui, Haian Fu, Gregory B. Melikyan	2015	27
10	Stress Induces p38 MAPK-Mediated Phosphorylation and Inhibition of Drosha-Dependent Cell Survival Molecular Cell ·Qian Yang, Wenming Li, Hua She, Juan Dou, Duc M. Duong, Yuhong Du, Shao‐Hua Yang, Nicholas T. Seyfried, Haian Fu, Guodong Gao, Zixu Mao	2015	63
11	Cables1 Complex Couples Survival Signaling to the Cell Death Machinery Cancer Research ·Zhi Shi, Hae Ryoun Park, Yuhong Du, Zijian Li, Kejun Cheng, Shi‐Yong Sun, Zenggang Li, Haian Fu, Fadlo R. Khuri	2014	33
12	A Time-Resolved Fluorescence Resonance Energy Transfer Assay for High-Throughput Screening of 14-3-3 Protein–Protein Interaction Inhibitors Assay and Drug Development Technologies ·Yuhong Du, Robert W. Fu, Bin Lou, Jing Zhao, Min Qui, Fadlo R. Khuri, Haian Fu	2013	22
13	Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathway Oncology Reports ·Meijuan Chen, Yuhong Du, Min Qui, Mingyan Wang, Kejun Chen, Zhenzhou Huang, Miao Jiang, Fei Xiong, Jianping Chen, Jing Zhou, Jiang Fengrong, Lian Yin, Yu‐Ping Tang, Lihong Ye, Zhen Zhan, Jin‐Ao Duan, Haian Fu, Xu Zhang	2012	70
14	A Dual-Readout F ² Assay That Combines Fluorescence Resonance Energy Transfer and Fluorescence Polarization for Monitoring Bimolecular Interactions Assay and Drug Development Technologies ·Yuhong Du, Zaneta Nikolovska‐Coleska, Min Qui, Lian Li, Iestyn Lewis, Raymond Dingledine, Jeanne A. Stuckey, Krzysztof Krajewski, Peter P. Roller, Shaomeng Wang, Haian Fu	2011	16
15	A Novel High-Throughput Screening Assay for Discovery of Molecules That Increase Cellular Tetrahydrobiopterin SLAS DISCOVERY ·Li Li, Yuhong Du, Wei Chen, Haian Fu, David G. Harrison	2011	6
16	Identification of novel small-molecule compounds that inhibit the proproliferative Kruppel-like factor 5 in colorectal cancer cells by high-throughput screening Molecular Cancer Therapeutics ·Agnieszka B. Bialkowska, Yuhong Du, Haian Fu, Vincent W. Yang	2009	31
17	Distinct growth factor-induced dynamic mass redistribution (DMR) profiles for monitoring oncogenic signaling pathways in various cancer cells Journal of Receptors and Signal Transduction ·Yuhong Du, Zijian Li, Lian Li, Zhuo Chen, Shi‐Yong Sun, Peifang Chen, Dong M. Shin, Fadlo R. Khuri, Haian Fu	2009	15
18	A Homogenous Luminescent Proximity Assay for 14-3-3 Interactions with Both Phosphorylated and Nonphosphorylated Client Peptides PubMed ·Yuhong Du, Fadlo R. Khuri, Haian Fu	2008	16
19	Down-regulation of 14-3-3ζ suppresses anchorage-independent growth of lung cancer cells through anoikis activation Proceedings of the National Academy of Sciences ·Zenggang Li, Jing Zhao, Yuhong Du, Hae Ryoun Park, Shi‐Yong Sun, Leon Bernal‐Mizrachi, Alastair Aitken, Fadlo R. Khuri, Haian Fu	2007	128
20	Photic regulation of arylalkylamine N-acetyltransferase binding to 14-3-3 proteins in retinal photoreceptor cells Journal of Neuroscience Nursing ·Nikita Pozdeyev, Carla G. Taylor, Rashidul Haque, Shyam S. Chaurasia, Amy Visser, Aamera Thazyeen, Yuhong Du, Haian Fu, Joan L. Weller, David C. Klein, P. Michael Iuvone	2006	2

About Yuhong Du

Yuhong Du is a scholar working on Molecular Biology, Virology, Computational Theory and Mathematics, Cell Biology and Molecular Medicine, having authored 96 papers that have together received 3.0k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (20 papers), 14-3-3 protein interactions (19 papers), Computational Drug Discovery Methods (10 papers), Protein Degradation and Inhibitors (7 papers), Microbial Natural Products and Biosynthesis (7 papers), Microtubule and mitosis dynamics (6 papers), ATP Synthase and ATPases Research (6 papers) and Heat shock proteins research (6 papers). The work is most often cited by research in Molecular Medicine (205 citations), Molecular Biology (1.9k citations), Pharmacology (304 citations), Cancer Research (268 citations) and Toxicology (55 citations). Yuhong Du has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Haian Fu, Fadlo R. Khuri, Jing Zhao, Min Qui, Raymond Dingledine, Aiming Sun, James P. Snyder, Xiulei Mo, Iestyn Lewis and Shi‐Yong Sun. Their work appears in journals such as Journal of Molecular Cell Biology, Proceedings of the National Academy of Sciences, Assay and Drug Development Technologies, SLAS DISCOVERY and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact